Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
This study has been terminated.
Study NCT00059644   Information provided by Mitsubishi Tanabe Pharma Corporation
First Received: April 29, 2003   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Peripheral Vascular Disease
Additional conditions recognized in this trial
Ischemia
Peripheral Vascular Diseases
Vascular Diseases
More general conditions related to this trial
Cardiovascular Diseases
Pathologic Processes
Interventions listed in this trial
Ecraprost in lipid emulsion
Sponsors listed in this trial
Mitsubishi Tanabe Pharma Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services